BackTwist Bioscience Overview
Twist Bioscience Corp

Twist Bioscience Target Price

Analysts' average 12-month price target for Twist Bioscience is $100.

Get informed when a big investor buys or sells

+ Follow

Share Price

$127.22

Average Target Price

$103.1518.9% downside

13 analysts in the last 4 months

High: $144 | Low: $80

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-09UBS$14413.2% upsideOpen
2026-08-05Piper Sandler$1159.6% downsideOpen
2026-08-04Robert W. Baird$1159.6% downsideOpen
2026-07-16Leerink PartnersPuneet Souda$11013.5% downsideOpen
2026-07-14Canaccord GenuityKyle Mikson$1205.7% downsideOpen
2026-07-06Evercore ISI$10219.8% downsideOpen
2026-06-29Guggenheim$10715.9% downsideOpen
2026-06-24BarclaysLuke Sergott$9525.3% downsideOpen
2026-06-15Cowen & Co.$8930% downsideOpen
2026-06-15Canaccord Genuity$9029.3% downsideOpen
2026-06-15UBS$8930% downsideOpen
2026-06-11Piper SandlerDavid Westenberg$8533.2% downsideOpen
2026-05-22Leerink PartnersPuneet Souda$8037.1% downsideOpen
2026-05-05GuggenheimSubbu Nambi$6052.8% downsideOpen
2026-05-05Robert W. BairdCatherine Ramsey Schulte$6548.9% downsideOpen
2026-05-04Barclays$6548.9% downsideOpen
2026-04-14BarclaysLuke Sergott$5556.8% downsideOpen
2026-02-03Robert W. Baird$5060.7% downsideOpen
2026-02-03Evercore ISI$5259.1% downsideOpen
2026-02-03Barclays$5060.7% downsideOpen
2026-01-05Evercore ISI$4267% downsideOpen
2025-12-15Barclays$3969.3% downsideOpen
2025-11-03StephensSteven Etoch$4167.8% downsideOpen
2025-10-02Barclays$4068.6% downsideOpen
2025-08-04Evercore ISI$4663.8% downsideOpen
2025-05-06Robert W. BairdCatherine Ramsey Schulte$4465.4% downsideOpen
2025-03-28Guggenheim$5060.7% downsideOpen
2025-02-04Robert W. BairdCatherine Ramsey Schulte$5457.6% downsideOpen
2025-02-03BarclaysLuke Sergott$5854.4% downsideOpen
2024-09-17Robert W. BairdCatherine Schulte$4663.8% downsideOpen
2024-06-05GuggenheimSubbu Nambi$5358.3% downsideOpen
2024-05-03Robert W. BairdCatherine Ramsey Schulte$4068.6% downsideOpen
2024-01-17Goldman SachsMatthew Sykes$4564.6% downsideOpen
2023-02-05BarclaysLuke Sergott$3274.8% downsideOpen
2023-01-03Evercore ISI$3671.7% downsideOpen
2022-10-06BarclaysLuke Sergott$4564.6% downsideOpen

Twist Bioscience (TWST) FAQ

Twist Bioscience posts a target price of $100. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $100 for TWST means covering analysts, on average, see the stock 18.9% downside of $127.22 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for TWST's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Twist Bioscience's other metric pages and overview cover the third.

Judging Twist Bioscience against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $100 here, then scan peer and history charts to see if the gap is persistent.